| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 00:30 | US IPO Weekly Recap: Biotech, early-stage mining, and Bill Ackman close out the April IPO market | ||
| Fr | US IPO Week Ahead: May IPO market kicks off with defense tech and soft drinks | ||
| Fr | SPAC CCIS Acquisition withdraws $60 million IPO | ||
| Fr | Neuropsychiatric therapeutics Seaport Therapeutics prices upsized IPO at $18, the high end of the range | ||
| Fr | Renaissance Capital's April IPO Market Update | ||
| Fr | SPAC Quantum Leap Acquisition prices $200 million IPO, targeting AI, quantum computing, and blockchain | ||
| Fr | SPAC CH4 Natural Solutions prices $200 million IPO, targeting businesses with real-asset footprints | ||
| Fr | Hemab Therapeutics prices upsized IPO at $18, the high end of the range | ||
| Do | Ammunition manufacturer First Breach files for a direct listing on the Nasdaq | ||
| Do | Exploration-stage mining company Silver Bow Mining prices upsized IPO at the $11.50 midpoint | ||
| Do | Coagulation disorder biotech Hemab Therapeutics Holdings ups shares offered by 27% ahead of $255 million IPO | ||
| Do | SPAC Forefront Tech Holdings Acquisition prices $100 million IPO, targeting AI and robotics | ||
| Do | SPAC General Catalyst Global Resilience Merger prices $350 million IPO, targeting aerospace and defense | ||
| Do | SPAC Mountain Crest Acquisition 6 prices $60 million IPO, led by Suying Liu | ||
| Do | SPAC West Enclave Merger prices $100 million IPO, targeting Latin America-focused businesses | ||
| Do | Pulmonary fibrosis biotech Avalyn Pharma prices upsized IPO at $18, the high end of the range | ||
| Do | SPAC GSR V Acquisition files for a $200 million IPO, targeting companies with leading market positions | ||
| Mi | SPAC Aussie Aussie Acquisition files for a $100 million US IPO, targeting defensible market positions | ||
| Mi | Pulmonary fibrosis biotech Avalyn Pharma increases shares offered by 41% ahead of $283 million IPO | ||
| Mi | Bill Ackman's closed-end fund Pershing Square USA prices $5 billion IPO at $50 per share; manager Pershing Square Inc. also set to trade on the NYSE | ||
| Mi | IPO Weekly Weigh-in: Kraken's pre-IPO haircut? | ||
| Mi | SPAC Collective Acquisition II prices $220 million IPO, targeting finance, defense technology, and AI | ||
| Di | Malaysian fintech AsiaFIN Holdings revises terms, changes underwriter ahead of $19 million US IPO | ||
| Di | Exploration-stage mining company Rare Earths Americas sets terms for $50 million IPO | ||
| Di | SPAC Plutonian Acquisition II prices $100 million IPO, targeting energy storage and telecom |